Skip to main content

Language: English / Gàidhlig

Loading…

Gabh pàirt

PE1884: Make whole plant cannabis oil available on the NHS or alternative funding put in place

Petition summary

Calling on the Scottish Parliament to urge the Scottish Government to make whole plant cannabis oil available on the NHS, or provide funds for private access, for severely epileptic children and adults where all other NHS epileptic drugs have failed to help.

Petitioner: Steve Gillan

Status: Closed

Date published: 22 July 2021

Click here for the full petition


Citizen Participation and Public Petitions Committee Consideration

SPICe briefing (216KB, pdf) posted 19 August 2021

 SPICe literature review (240KB, pdf) posted 25 February 2022

Committee Meetings

22 September 2021: The Committee agreed to write to the Cabinet Secretary for Health and Social Care. The Committee also agreed to seek further background information on the issues raised in the petition and to write to the petitioner.

Official Report of Meeting 22 September 2021

23 March 2022: The Committee agreed to write to the Cabinet Secretary for Health and Social Care and the Minister for Drugs Policy.  

Official Report of Meeting 23 March 2022

28 September 2022: The Committee agreed to write to the Scottish Government. 

Official Report of Meeting 28 September 2022

22 March 2023: The Committee agreed to close the petition under Rule 15.7 of Standing Orders

Official Report of Meeting 22 March 2023 (, ) posted 28 March 2023


Written submissions

PE1884/A: Chief Pharmaceutical Officer submission of 19 August 2021

PE1884/B: Petitioner submission of 12 September 2021

PE1884/C: Cabinet Secretary for Health and Social Care submission of 28 January 2022

 PE1884/D: Petitioner submission of 15 March 2022  (59KB, pdf) posted 16 March 2022

PE1884/E: Cabinet Secretary for Health and Social Care submission of 26 April 2022  (64KB, pdf) posted 03 May 2022

PE1884/F: Cabinet Secretary for Health and Social Care submission 8 June 2022  (11KB, pdf) posted 15 June 2022

PE1884/G: Interim Chief Pharmaceutical Officer submission of 17 October 2022  (9KB, pdf) posted 20 October 2022